ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 16.0077 ↓ -1.21%
[as on 23 January, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option -5.89% -1.21% -4.03% -6.98% -10.85% -9.32% 18.23%---

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.31% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.69%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.96%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.97%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services6.35%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.71%
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.51%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology4.43%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services3.98%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.70%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services3.62%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology3.07%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology3.04%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.95%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology2.82%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology2.57%
Wockhardt LimitedWOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology2.27%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.20%
Healthcare Global Enterprises LimitedHCG (INE075I01017)Healthcare Services1.77%
Glenmark Pharmaceuticals LimitedGLENMARK (INE935A01035)Pharmaceuticals & Biotechnology1.73%
Laurus Labs LimitedLAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology1.69%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.53%
FDC LimitedFDC (INE258B01022)Pharmaceuticals & Biotechnology1.40%
Sumitomo Chemical India LimitedSUMICHEM (INE258G01013)Fertilizers & Agrochemicals1.35%
SBI Life Insurance Company LimitedSBILIFE (INE123W01016)Insurance1.25%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.23%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology1.22%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology1.21%
Onesource Specialty Pharma LimitedONESOURCE (INE013P01021)Pharmaceuticals & Biotechnology1.19%
Rainbow Childrens Medicare LimitedRAINBOW (INE961O01016)Healthcare Services1.19%
Orchid Pharma LimitedORCHPHARMA (INE191A01027)Pharmaceuticals & Biotechnology1.13%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology1.13%
Standard Glass Lining Technology LtdSGLTL (INE0M4D01010)Industrial Manufacturing1.05%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology0.99%
Poly Medicure LimitedPOLYMED (INE205C01021)Healthcare Equipment & Supplies0.93%
Caplin Point Laboratories LimitedCAPLIPOINT (INE475E01026)Pharmaceuticals & Biotechnology0.86%
Supriya Lifescience LimitedSUPRIYA (INE07RO01027)Pharmaceuticals & Biotechnology0.85%
Linde India LimitedLINDEINDIA (INE473A01011)Chemicals & Petrochemicals0.81%
Shilpa Medicare LimitedSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology0.75%
UPL LimitedUPL (INE628A01036)Fertilizers & Agrochemicals0.72%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology0.70%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.48%

Debt

NameRatingWeight %
Portfolio data is as on date 31 October, 2025

NAV (Net asset value) history

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option - 30 days NAV history

DateNAV
23 January, 202616.0077
22 January, 202616.2044
21 January, 202616.0343
20 January, 202616.1657
19 January, 202616.5520
16 January, 202616.6807
14 January, 202616.8414
13 January, 202616.8812
12 January, 202616.8911
9 January, 202617.0027
8 January, 202617.1990
7 January, 202617.4366
6 January, 202617.3186
5 January, 202617.0841
2 January, 202617.1355
1 January, 202617.0101
31 December, 202517.0636
30 December, 202516.9104
29 December, 202517.0224
26 December, 202517.1096
24 December, 202517.1650
23 December, 202517.2084
22 December, 202517.2622
19 December, 202517.1563
18 December, 202516.9670
17 December, 202516.9934
16 December, 202517.1180
15 December, 202517.2020
12 December, 202517.2581
11 December, 202517.2167

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 16.0077 as on 23 January, 2026.
  • What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are -5.89% as on 23 January, 2026.
  • What are 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are -9.32% as on 23 January, 2026.
  • What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 18.23% as on 23 January, 2026.